서브메뉴

Emerging Innovators
What's on This Episode
About the Program
Video on Demand
Special VOD
Archive
TV Programs 고르기
Staff and Cast
Executive Producer
- Park Hyung-sil
Producer
- Park Hyon-son
Writer
- Lee Hyun-kyung
- Han Song-yi
- Choi Sun-young
- Jeong Hye-su
English Writer
- Lee Ju-young
Narration
- Kwon So-a
Director
- Kim Kyoung-su
- Lee Jae-ak
- Kim Jong-hwan
Assistant Director
- Lee Jun-ho
- Park Ye-Seul

Emerging Innovators

Ep.11 G2GBIO / YiPSCELL / GENOME&COMPANY / NSTBIO

World Ch. Schedule : TUE 08:30 KST

Date : 2021-02-18

Emerging Innovators - Ep.11
G2GBIO, paving a new path for dementia treatment

G2GBIO is a company that has strived hard to help dementia patients live a better life. It has developed sustained release microsphere drugs and it has already completed the Pre-IND meeting with the U.S. FDA. Also, the company has developed drugs for diabetes and pain treatments as part of an effort to improve health of people around the world.

For more information on the company: contactus@g2gbio.com

#G2GBIO #dementia_treatment #microsphere_injection #membrane_emulsification #Korea_Institute_of_Toxicology #EMERGING_INNOVATORS #ArirangTV

BizSmart
YiPSCELL, leading the IPS Cell technologies

YiPSCELL has developed induced pluripotent stem cells for the first time in Korea. By making use of induced pluripotent stem cells, the company developed “MIUChon™” which can regenerate cartilage only with an injection, without additional surgeries. It has applied for patents in the U.S., Europe and Japan. And it is preparing for clinical trials with the aim of releasing the treatment in 2023.

For more information on the company: support@yipscell.com

#induced_pluripotent_stem_cell #osteoarthritis_treatment #MIUChon™ #pipeline #toxicity_test #Korea_Institute_of_Toxicology #EMERGING_INNOVATORS #ArirangTV

BizSmart
GENOME & COMPANY, a leading business in cancer immunotherapy

GENOME&COMPANY has developed new drugs for cancer immunotherapy by using microbiome. The company has built its own platform to discover candidate substances for new drugs based on the accumulated experience and clinical data. “GEN-001,” which is one of the major pipelines of the company, is a candidate for the oral microbiome-based drug which can provide an anti-cancer effect.

For more information on the company: contact@genomecom.co.kr

#microbiome #GENOME_COMPANY #cancer_immunotherapy #GEN001 #GENA104 #Korea_Institute_of_Toxicology #EMERGING_INNOVATORS #ArirangTV

BizSmart
NSTBIO, a developer of advanced fermentation skills

NSTBIO produces high-quality biofood based on its advanced fermentation technologies. The company aims to popularize K-Food by implementing Korea’s traditional fermentation methods, its own fermentation skills and the excellence of medicinal food. Also, it is planning to make advancement into the global market and boost export by developing different products for local residents.

For more information on the company: nstbio@nstbio.co.kr

#NSTBIO #Noni #ALLBIO #functional_food_for_health #BIG3 #Korea_Institute_of_Toxicology #EMERGING_INNOVATORS #ArirangTV

BizSmart